US 10,238,707 B2 · Composition for the prevention and/or treatment of allergy symptoms

Abstract

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. In particular, the composition according to the invention comprises at least one slow release component comprising quercetin and at least one fast release component comprising an extract from Perilla frutescens or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechina, ferulic acid, caffeic acid or mixtures thereof, The invention further comprises the use of the composition in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms.

Claims15

Dependent claims

Composition comprising:

at least one slow release component comprising quercetin;
and
at least one fast release component comprising an extract from Perilla frutescens or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechin, acid, caffeic acid or mixture thereof.

Dependencies are inferred from the claim text.

Facts

Application

16/018,381Filed 26 Jun 2018 · continuation

Priority

IT MI2014A164122 Sep 2014

Published

US 2018/0296621 A118 Oct 2018

Granted

26 Mar 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 36/535
Lamiaceae or Labiatae , e.g. thyme, rosemary or lavender: perilla
A23L 33/105
Using additives: plant extracts, their artificial duplicates or their derivatives
A61K 9/2013
Excipients; Inactive ingredients: organic compounds, e.g. phospholipids, fats
A61K 9/209
Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat: containing drug in at least two layers or in the core and in at…

Family

PCT/IB2015/057267Parent of this continuation · filed 21 Sep 2015

US 2018/0296621 A1Pre-grant publication · published 18 Oct 2018

Application15/504,117Parent of this continuation

US 10,143,715 B2Related patent

US 2017/0258864 A1Published application

US 10,238,707 B2This patent

From the US filing history. Foreign family members aren’t listed.

Composition for the prevention and/or treatment of allergy symptoms

Life of this patent

Composition for the prevention and/or treatment of allergy symptoms

Life of this patent

Abstract

Claims15